Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by prophetoffactzon Jun 22, 2023 4:40pm
59 Views
Post# 35510003

RE:RE:RE:RE:RE:RE:AVN trial delays

RE:RE:RE:RE:RE:RE:AVN trial delaysThe 6 month push out of the PGX scale up completion has yet to be explained and the date was pushed out months after the date was set.

In the August 4, 2022 Small Cap Discoveries interview at 12:15 Gilles expected to be on the market in 12-18 months he said. 
Ceapro (TSX.V: CZO) Interview with CEO Gilles Gagnon - YouTube

That was before CZO had even signed the site agreement with the University of Alberta where they now plan to scale-up. The site agreement was signed in November 2022. In other words, it was a rough estimate before signing the site license and moving in, etc. That 12-18 month timeline estimate would take us potentially to Feb 4, 2024. The current expectation, with the site license signed, and CZO in the facility, and a clearer picture, is for commissioning of the facility by June 2024 and Gilles noted that they may have identified ways to save time and costs. In other words, having signed the site license and moved into the facility, and advanced and re-calibrate their plans with boots on the ground CZO is still within the ballpark of its original 12-18 month timeline. They have never built a facility at this scale and the technology has never been proven at this new scale. As Gilles has noted there are many calculations. The timeines are not to be taken as garentees but preliminary and subject to new information as the project advances or doesn't. Once CZO has built a facility at this scale the construction of a second facility at this scale will be more predictable having done it before. 
<< Previous
Bullboard Posts
Next >>